NovoCure (NVCR) Total Liabilities (2014 - 2026)
NovoCure (NVCR) posted Total Liabilities of $457.1 million for Q2 2026, little changed sequentially from $457.2 million in Q1 2026, and down 49.01% YoY from $896.4 million in Q2 2025.
NovoCure (NVCR) Total Liabilities (2014 - 2026) Analysis & Trends
NovoCure has reported Total Liabilities for 13 years, with the latest figure at $457.1 million in Q2 2026.
- Quarterly Total Liabilities fell 49.01% year-over-year to $457.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $457.1 million (down 49.01% YoY) and the FY2025 annual result came in at $463.9 million, down 47.32% from the prior year.
- Total Liabilities steadied at $457.1 million in Q2 2026 per NVCR's latest filing, from $457.2 million in the prior quarter.
- Over five years, Total Liabilities peaked at $1.0 billion in Q3 2025 and troughed at $457.1 million in Q2 2026.
- A 5-year average of $748.4 million and a median of $751.6 million in 2022 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2025 and 2026: Total Liabilities climbed 18.42% in 2025, then slumped 49.01% in 2026.
- Over 5 years, Total Liabilities stood at $750.5 million in 2022, then grew by 4.42% to $783.6 million in 2023, then grew by 12.37% to $880.6 million in 2024, then plunged by 47.32% to $463.9 million in 2025, then fell by 1.46% to $457.1 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $457.1 million, $457.2 million, and $463.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 23.94 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 42.96 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 3.14 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.83 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 26.03 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 17.70 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.51 Bn |
| 10 | NovoCure | 2.06 Bn | 1.62 Bn | 142.48 Mn | 457.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 457.10 Mn |
| Mar 31, 2026 | 457.21 Mn |
| Dec 31, 2025 | 463.86 Mn |
| Sep 30, 2025 | 1.02 Bn |
| Jun 30, 2025 | 896.43 Mn |
| Mar 31, 2025 | 886.85 Mn |
| Dec 31, 2024 | 880.61 Mn |
| Sep 30, 2024 | 861.21 Mn |
| Jun 30, 2024 | 850.42 Mn |
| Mar 31, 2024 | 762.07 Mn |
| Dec 31, 2023 | 783.63 Mn |
| Sep 30, 2023 | 752.65 Mn |
| Jun 30, 2023 | 743.33 Mn |
| Mar 31, 2023 | 742.19 Mn |
| Dec 31, 2022 | 750.48 Mn |
| Sep 30, 2022 | 728.81 Mn |
| Jun 30, 2022 | 721.00 Mn |
| Mar 31, 2022 | 714.33 Mn |
| Dec 31, 2021 | 729.00 Mn |
| Sep 30, 2021 | 707.29 Mn |